INTRODUCTION
Clinical microbiology has been an especially dynamic discipline during the past 10 to 15 years. The exciting developments include the recognition of several new etiologic agents, the reemergence of some classic pathogens, development of molecular diagnostic tools, and automation of antimicrobial susceptibility testing and microbial identification. This article explores the development of automated identification systems and reviews their performance.
To limit confusion, we will avoid terms often used in the literature such as semiautomated or partially automated. Webster's Dictionary defines automation as the "automatically controlled operation of an apparatus, process, or system by mechanical or electronic devices that take the place of human organs of observation, effort, and decision" (77a) . None of the systems described is totally automated. We use the term "automated" to describe the instruments discussed here and trust the reader to understand that some instruments are more automated than others.
The criteria used for inclusion of an instrument in this review are as follows. (i) The minimum requirement is automated result entry and identification of microorganisms. Systems requiring manual result entry are not discussed. (ii) The instrument must have a data base for the identification of a large variety of different microorganisms. Instruments such as automated enzyme immunoassay systems that identify a relatively small number of microorganisms are not described. (iii) The instrument must be available in the United States.
For studies that have compared the identification accuracy of two or more automated identification systems, the percentile (P value) of the chi-square distribution as determined by the chi-square test has been calculated.
The development of the first generation of automated equipment for clinical microbiology involved essentially two approaches. One can be described as the mechanization of existing techniques. The second combined mechanization with other changes, such as miniaturization and/or incorporation of innovative substrates, inhibitors, or indicators. The * Corresponding author.
primary goal was to enhance data acquisition and processing, particularly with regard to decreasing turnaround time.
Although the instruments available today are improvements over the original formulations, they still represent the first generation of instruments used to identify microorganisms. These instruments are widely accepted and very helpful; however, like the instruments used in clinical chemistry and hematology laboratories, they will continue to evolve to better meet the needs of the clinical microbiology laboratory. If we compare the modem clinical chemistry analyzer, with its discrete multianalytes requiring no sample preparation, with instruments available in clinical chemistry during the 1960s, we believe we get a glimpse of what the future can be in microbiology. At the very least, we should target that level of automation for clinical microbiology and expect future generations of equipment to be highly automated, cost-effective, accurate, reliable, and flexible and to provide rapid turnaround time.
Among the first automated microbial identification systems were the Autobac Series II (formerly called the Autobac; Organon-Teknika, Durham, N.C.) and the Avantage Microbiology Center (formerly called the Abbott MS-2) and Quantum II Microbiology System (Abbott Laboratories Diagnostic Division, Irving, Tex.). These systems are no longer manufactured but are still in service in some laboratories. As an introduction to the systems used for automated identification, we believe that it is appropriate to provide a brief review of these systems.
The Autobac Series II uses a 19-chambered plastic cuvette and automatically interprets results of biochemical tests. One chamber is a growth control, and the other 18 contain substrates composed of antibiotics, dyes, or other chemicals. Common members of the family Enterobacteriaceae and six species or groups of nonfermentative and oxidasepositive gram-negative bacilli can be identified by differential growth inhibition. After off-line incubation of the cuvette for 3 to 6 h, a photometer automatically determines growth inhibition by analyzing the light-scattering index of each chamber. A two-stage quadratic discriminant analysis program is then used to identify the isolate.
Early studies of the Autobac Series II with currently used substrates demonstrated that 87 .7 to 94.8% of the organisms Inc., Hazelwood, Mo.). The Vitek system will be described later in this paper. In this study, Barry et al. (10) (120) . In the study of Truant et al. (120) , the Autobac Series II correctly identified 82.3% of the tested isolates, versus 95 .6% for the Vitek system (P < 0.001).
The Avantage Microbiology Center and Quantum II Microbiology System use a 20-chamber (oxidase and indole test results for bacteria and the germ-tube test result for yeasts are manually entered) with a probability matrix.
There have been two reports of the Avantage BIC with currently used substrates. Jorgensen et al. (55) reported the results of a collaborative evaluation of the Avantage BIC used to identify commonly isolated nonfermentative or oxidase-positive gram-negative bacilli in 5 h. Conventional biochemicals were used as the reference system. The organisms included in the data base were Acinetobacter anitratus, Acinetobacter iwoffi, Aeromonas hydrophila, Flavobacterium meningosepticum IIb group, P. aeruginosa, P. cepacia, Pseudomonas fluorescens-Pseudomonas putida group, X. maltophilia, and Plesiomonas shigelloides. In phase I of the study, 200 challenge strains were tested by each of three laboratories. The overall accuracy was 96%, with 95% correct results for isolates in the data base and 98% for recognition of biotypes not in the data base. Of 200 isolates, 11 either produced a correct identification with low likelihood (probability, <80%) or required tests of oxidative fermentation of glucose or 10% lactose to separate A. anitratus from A. iwoffi. In phase II, 100 to 200 routine clinical isolates or selected stock strains were tested by each laboratory. In phase II, 95% of the isolates were correctly identified. Only 11 (2.5%) of 437 isolates yielded a low likelihood of identification, and only 4 (4%) of 103 isolates not in the Avantage data base produced misidentifications. P. fluorescens-P. putida presented a significant problem, with only 17 of 21 isolates correctly identified.
The other report on the Avantage BIC was an abstract by Snyder et al. (109) . Of (25) . One hundred eighteen yeast isolates grown on Sabouraud dextrose agar with and without penicillin (20 U/ml) and streptomycin (40 U/ml) were identified by the YIC and conventional methods. The identity of isolates grown on the nonselective and selective media and identified by the YIC agreed with results obtained from conventional methods 80 and 83% of the time, respectively. Of 18 isolates grown on Mycosel agar, 17 (94%) were correctly identified. All isolates of Candida albicans (N = 7), Candida tropicalis (N = 13), Candida glabrata (N = 7), and Cryptococcus neoformans (N = 15) grown on selective media were correctly identified by the YIC.
Kiehn et al. (61) 4 isolates were unidentified even though they were in the Quantum II data base. C. parapsilosis, which was not in the data base, was most frequently misidentified, followed by C. tropicalis and Geotrichum spp. Multiple false-positive and false-negative reactions were responsible for most of the misidentifications. The authors speculated that standardization of the inoculum with a spectrophotometer or hemacytometer might enhance the performance of the system. Compared with the Quantum II YIC, the Vitek correctly identified 83% of the isolates (P > 0.05).
Recent abstracts regarding the Quantum II YIC have reported that 91 and 99% of the tested yeasts were correctly identified (5, 48) .
In summary, early studies with the Autobac Series II demonstrated that most of the gram-negative bacilli commonly isolated in the clinical laboratory were correctly identified (10, 11, 18, 27, 60, 106, 111) . However, problems were reported in the identification of such organisms as Enterobacter cloacae, C. freundii, Proteus vulgaris, Providencia spp., Salmonella spp., Shigella spp., P. cepacia, and many uncommon organisms. Truant et al. (120) demonstrated additional unexplained problems in identification of some common organisms such as E. coli, Proteus mirabilis, and P. aeruginosa. The most recent versions of the Avantage BIC correctly identified approximately 95% of the gram-negative bacillus strains tested (55, 116) , whereas the most recent version of the Quantum II BIC correctly identified approximately 92% of typical and atypical gramnegative bacillus strains tested (98) . Organisms that particularly posed identification problems for the Abbott identification systems included P. fluorescens, P. putida, Serratia spp., and uncommon organisms. The MS-2 YIC (26), Avantage YIC (25) , and Quantum II YIC (61, 94, 102, 104) performed well in the identification of common yeast isolates, but less commonly encountered yeasts were frequently misidentified. The number of genera, species, or groups of gram-negative bacilli or yeasts in the data base of the Autobac Series II or Abbott identification systems is limited. Consequently, these early identification systems have had significant problems in identification of uncommon organisms and newly recognized genera.
These first automated identification systems are of historical importance and can serve as a reference of performance level for the systems to be described in this review. 6 Cryptococcus species, 3 Rhodotorula species, 2 Tnichosporon species, 3 Geotnichum species, 2 Prototheca species, and single species of four additional genera.
The Vitek system is an integrated modular system consisting of a filling-sealer unit, reader-incubator, computer control module, data terminal, and multicopy printer. The Vitek system can be purchased with a capacity of 30, 60, 120, or 240 cards and can be interfaced with other computers. A data management center can be added.
Inocula for the identification cards are prepared from selective (GNI or GPI) or nonselective (GNI, GPI, and YBC) agar media. Inocula for the GNI, GPI, and YBC are prepared by suspending several colonies in 1.8 ml of 0.45 to 0.5% saline and adjusting the suspension to the equivalent of a no. 1 (GNI and GPI) or a no. 2 (YBC) McFarland standard. The inoculum is automatically transferred to the card via a transfer tube during the vacuum cycle of the filling module. The GNI and GPI are placed in plastic trays, each tray holding up to 30 cards. The tray is placed in the readerincubator at 35°C, and at hourly intervals a digitized analog optical reading, proportional to the light attenuation for each test well, is obtained for each card. The first reading usually establishes a baseline value, and the amount of light reduction caused by growth or a biochemical reaction in the microwell is determined on subsequent readings. A predetermined minimum change is required to differentiate between positive and negative reactions. Final identification by the GNI is reported between 4 and 18 h. Most of the non-glucose-fermenting gram-negative bacilli are reported at 18 h. Organisms are identified by the GPI between 4 and 15 h. The YBC is incubated off-line at 30°C for 24 h and then placed in the reader-incubator for a single reading. A message "reincubate for 24 h at 30°C" indicates that a definitive identification requires more incubation time. At 48 h, one must fill in the 48H mark on the card and obtain a second reading. The biochemical test results for all cards are compared with the data base, and the first and second choices, as well as their absolute likelihoods and normalized percent probabilities, are reported. The biochemical test results, as well as supplemental tests if required, are printed.
The Vitek system original gram-negative identification card was called the Enterobacteriaceae Biochemical Card (EBC) and was designed for the identification of members of the family Enterobacteriaceae within 8 h. The EBC contained 23 conventional biochemical substrates, 2 inhibitors, and 1 nonconventional substrate. Even though the original Vitek system had a limited data base, numerous studies found the EBC to correctly identify 92 to 99% of the tested organisms (7, 12, 17, 29, 39, 41, 50, 53, 58) . Organisms not represented in the data base, uncommon organisms, and incorrect reactions for certain biochemicals such as adonitol, arginine, citrate, H2S, and malonate were responsible for most misidentifications. The lack of an indole reaction was also considered a weakness of the system. Ferraro et al. (39) found that commonly isolated members of the family Enterobacteriaceae could be presumptively identified by the EBC in 4 h. They found that 97% of the members of the Enterobacteriaceae isolated in their laboratory belonged to 11 species of six genera. When the EBC was limited to those 11 species, 83% of the isolates were correctly identified to genus or species at 4 h. Two percent of the isolates were misidentified, and 15% were not reported until 8 h.
Vitek then introduced the EBC+, which, with the addition of acetamide, cetrimide, glucose oxidation, and a supplemental oxidase test, was capable of identifying members of the family Enterobacteriaceae within 8 h and nonfermentative and oxidase-positive gram-negative bacilli within 18 h.
Studies of the EBC+ demonstrated that 90 to 96% of the members of the family Enterobacteriaceae and 86 to 97% of the gram-negative organisms that were not members of the Enterobacteriaceae tested were correctly identified (7-10, 44, 56, 125) . However, uncommon organisms were frequently misidentified or had a low percent likelihood of identification. The new substrates added to the EBC+ were of limited value in the identification of gram-negative organisms that were not members of the Enterobacteriaceae, and only Aeromonas iwoffi, Aeromonas hydrophila, and P. aeruginosa were consistently correctly identified (7, 8, 54, 108, 125 (3, 36) . Four studies of the GPI for identification of the viridans group showed an accuracy of 57.2 to 79%, and many of the strains were identified at a low level of confidence (3, 36, 92, 101 (49, 66, 88 . Morphological observations were needed to identify >50% of the isolates, and confirmatory biochemical tests were required for identification of 8% of the isolates by the YBC. As will be true for all of the automated identification systems considered, Vitek Systems has continued to improve the capability of its systems to accurately identify microorganisms. Consequently, when attempting to determine the performance of the Vitek system, one should consider the publications that have evaluated or compared the latest software, data base, biochemical configuration, or other performance characteristics of their system. In considering recent studies of the GNI, members of the family Enterobactenaceae were correctly identified in the range of 94.7 to 96.2%, with Enterobacter spp. the most frequently misidentified (24, 95, 120) . Gram-negative organisms that were not members of the Enterobactenaceae were correctly identified in the range of 79.6 to 95%, with P. aeruginosa and Acinetobacter spp. the most commonly misidentified (24, 38, 95, 120) . S. aureus, S. epidermidis, S. saprophyticus, S. xylosus, and S. haemolyticus have been correctly identified by the GPI in the range of 88 to 100%, but less commonly encountered species have frequently been misidentified or identified with a low likelihood (2, 45, 46, 72, 101) . Streptococcus pyogenes and species of group D streptococci and enterococci have been accurately identified with a high level of confidence by the GPI, but other Streptococcus species have posed more of a problem for the system (1, 3, 36, 51, 92, 101, 103) . In recent publications, the YBC correctly identified 93.5 to 98% of tested yeasts and yeastlike isolates, when organisms not represented in the data base were excluded and when required supplemental tests or morphological examinations were performed (34, 40, 77, 97, 107, 127) .
The Vitek system is a comprehensive microbial identification system that needs further improvement in its identification accuracy for some Staphylococcus and Streptococcus species, as well as for unusual and uncommon bacteria and yeasts. In addition, a shortened time for identification of non-glucose-fermenting gram-negative bacilli, gram-positive bacteria, and yeasts would be desirable. On-line incubation of the YBC, Anaerobe Identification Test Kit, Neisseria/ Haemophilus Identification Test Kit, and Enteric Pathogen Screen Test Kit cards would further enhance the utility of the Vitek system. Tables 1, 2 , 3, and 4 demonstrate the identification accuracy for members of the family Enterobacteriaceae, for strains of other gram-negative organisms, for Staphylococcus strains, and for strains of yeasts and yeastlike organisms, respectively, for each of the automated identification systems that can currently be purchased.
SENSMTTRE
The Sensititre fluorogenic system (Radiometer America, Inc., Westlake, Ohio) is a modular system composed of a computer and an automated reader. This system identifies gram-negative bacilli and performs susceptibility tests on both gram-positive and gram-negative bacteria in either 5 or 18 h. Breakpoint or MIC capability for gram-negative and gram-positive bacteria is available for 54 antimicrobial agents. The Sensititre AP80 panel data base includes information for the identification of 84 members of the family Enterobacteriaceae, 24 oxidase-positive fermenters, 16 pseudomonads, and 16 other nonfermenters.
The automated Sensititre system is composed of a Sensititre Fluorescence AutoReader, a Digital PRO 380 computer with 768K of main memory, 20 or 30 MB hard-disk and dual floppy-disk drives, data terminal, and multicopy printer. A Sensititre Automatic Inoculator is also available. The Sensititre software has menus for demographics, interpretation of culture results, data analysis, report generation, and epidemiological evaluations.
The Sensititre AP80 gram-negative identification test plate will test three separate organisms, with each section concence. Therefore, absence of fluorescence indicates a positaining 32 dried, fluorescently labeled substrates. Substrates tive test. In other cases (carbon assimilation reactions, are linked to a fluorophore (4-methylumbelliferone or 7-amidecarboxylase reactions, and urea hydrolysis), the pH is no-4-methylcoumarin). Some of the substrates (peptidase, increased, thus producing fluorescence. pyranosidase, phosphatase, and glucuronidase) do not diInocula are prepared, using a built-in nephelometer in the rectly fluoresce. However, when enzymes release the fluoAutomatic Inoculator, by transferring one or more colonies rophore, it will fluoresce. The fluorogenic reaction occurs from either nonselective or selective agar media to sterile when UV light is absorbed and electrons are raised to higher distilled water to equal a no. 0. inconclusive, and 7.0% unidentified. Because of the limitation inherent in an abstract, it was not stated whether isolates were correctly identified to genus or to species. Also, it was not stated whether these data applied to the 5-or 18-h identification with the AP80. Lyznicki Limitations of the Sensititre system include the requirement for off-line incubation of AP80 panels, the necessity of performing additional rapid tests for some isolates, and the necessity for reincubating some AP80 panels. In addition, the development of systems for the rapid identification of gram-positive bacteria, anaerobes, and yeasts would expand the utility of the Sensititre fluorogenic system. Radiometer America will introduce the ARIS (Automated Reading and Incubation System) to the United States in 1992. ARIS will provide "walk-away" automation and plate reading technology based on the Sensititre AutoReader.
The limited results available with the Sensititre AP80 identification system are very encouraging. However, further evaluation of this identification system, particularly in defining its accuracy for both common and uncommon organisms at both 5 The rapid fluorogenic panels for identification of gramnegative bacilli (R-GNB) and gram-positive bacteria (R-GPB) use fluorogenic substrates (4-methylumbelliferone or 7-amino-4-methylcoumarin attached to a phosphate, sugar moiety, or amino acid) or fluorometric indicators. Identification is based on hydrolysis of fluorogenic substrates, pH changes following substrate utilization, production of specific metabolic by-products, or the rate of production of specific metabolic by-products after 2 h of incubation. The modified conventional panel for identification of gram-negative bacilli (GNB) has 29 modified conventional or chromogenic tests and six antibiotics, and results are available in 15 to 42 h. Both the R-GNB and GNB data bases include information for identification of 59 groups, genera, or species of members of the Enterobacteriaceae and 57 groups, genera, or species of nonfermentative and oxidase-positive gram-negative bacilli. The modified conventional panel for identification of gram-positive bacteria (GPB) has 25 modified conventional or chromogenic substrates, one dye, and three antibiotics and yields an identification in 15 to 42 h. Both the R-GPB and GPB data bases include information for identification of 24 genera or species of the family Micrococcaceae, 18 The WalkAway-96 and WalkAway-40 are composed of an incubator, ultrasonic humidifier, carousel holding towers, bar code reader, spectrophotometer, fluorometric reader, reagent-dispensing subsystem, panel-accessing mechanism, and computer for panel scheduling and tracking. The auto-SCAN-4 is a colorimetric optical system that performs similarly to the spectrophotometer in the WalkAway-96 and WalkAway-40. Panels are processed one at a time after off-line incubation. The technologist communicates with these systems from the keyboard and monitor of an IBM Personal Computer AT or IBM Personal System/2 computer, model 60 or 80, via MicroScan Data Management System (DMS) software. The DMS produces chartable reports, epidemiologic reports, work logs, and antibiograms. The results can be displayed on a monitor or printed. A Pharm-Link program, which allows the pharmacy to interact with the MicroScan system, can be added. The DMS will support two MicroScan instruments and multiple workstations. One-or two-way interfaces with other computer systems are available. tested with the R-GNB. With the R-GNB, supplemental tests could be set up after the interpretation at 2 h. Only 13.5% of the GNB tests could be interpreted at 18 h, with the remainder requiring 42 h of incubation. When the identifications were recalculated with an updated R-GNB data base and revised software, 77.1% were correctly identified at >85% probability and 8.1% were misidentified at this same probability.
Published abstracts regarding the WalkAway-96 R-GNB have reported an identification accuracy that has varied from 66.4 to 97.8% (24, 30, 32, 47, 57, 59, 70, 75, 76, 87, 118) . Organisms reported in some studies to be frequently misidentified or to yield inconclusive results included K pneumoniae, K oxytoca, Enterobacter cloacae, C. freundii, Serratia marcescens, Proteus mirabilis, M. morganii, Shigella spp., and P. fluorescens (30, 32, 59, 75, 118) . One study reported that 21% of the P. aeruginosa isolates tested in the WalkAway-96 failed to grow and could not be identified (59) .
The original MicroScan GPB panel for identification of gram-positive bacteria was supplied and stored frozen and contained 27 tests. Tritz et al. (119) The API 20C was used as the standard method, and discrepancies were resolved with conventional assimilation and fermentation tests. The overall accuracy of the YIP was 59% when interpreted by the autoSCAN-4 and 72% when interpreted visually (P < 0.01). When biotypes not found in the data base were excluded, the accuracy was 62% by auto SCAN-4 and 76% by visual interpretation (P < 0.01). Morphological observations were needed to identify more than 50% of the isolates, and confirmatory biochemical tests were required for identification of 29% of the isolates by the autoSCAN-4 versus 16% by visual interpretation. Belcher et al. (14) (117) found that the WalkAway-96 GNB and R-GNB correctly identified 62.6 and 90.6%, respectively, of the gram-negative nonenteric bacilli tested. However, approximately 35 and 45%, respectively, of the correct identifications with the GNB and R-GNB had a probability of less than 85%. In addition, approximately 40% of the isolates required supplemental tests for correct identification by both the GNB and R-GNB.
Only 13.5% of the GNB results could be interpreted at 18 h, with the remainder requiring 42 h of incubation. A. xylosoxidans subsp. xylosoxidans, P. putida, P. fluorescens, and X. maltophilia were most frequently misidentified by the GNB, whereas P. fluorescens accounted for 28% of the misidentifications by the R-GNB. Published The MicroScan automated systems will identify a wide variety of organisms. However, further improvements in the data base and software for all panel types are needed. An automated method for the addition of mineral oil to the various panels and for inoculation of the HNID, AIP, and YIP would enhance work flow.
There have been no evaluations of the HNID panel and GPB dried-substrate panels by using MicroScans automated systems. Evaluation of the WalkAway-40 and further evaluation of the WalkAway-96 and autoSCAN-4 with appropriate MicroScan panel types will be required as Micro Scan continues to update the data bases and software programs. The ALADIN system is composed of an incubator, elevator, reagent-dispensing station, grabber arms, image processor, and disposal station. A separate workstation interacts with the ALADIN and is composed of a keyboard, computer (Compaq 386 Sx model 40), UniScept deziner-er Software, and Okidata 320 printer. The software contains the data base for all UniScept products, susceptibility programs, patient demographics, storage of data, and antibiograms. A bidirectional mainframe computer interface that allows up-load of daily test results and down-load of demographics may be purchased.
Inocula for the UniScept 20E and UniScept 20GP can be grown on either selective or nonselective agar media, whereas inocula for the AN-Ident must be grown on nonselective agar media (excluding 5% sheep blood Trypticase soy agar [TSA] (approximately 85 i±l) of the suspension. When the UniScept 20E is to be incubated off-line and then read on the UniScept AutoReader, the cupule section of the arginine, lysine, ornithine, urea, and H2S tubes must be manually overlaid with mineral oil.
The ALADIN has a 60-specimen-capacity incubator, with up to two UniScept panels (identification and/or susceptibility) being processed per specimen. This allows the processing of up to 120 individual panels. A virtually unlimited number of panels may be incubated off-line for reading on the ALADIN. One or two UniScept panels per specimen are placed in a universal carrier, which is a molded plastic frame approximately 5 by 85/8 in. (ca. 13 by 22 cm) in size. The panels are inoculated, and the universal carrier is placed into 1 of 60 test slots (two rows of 30) in the incubator. The elevator and grabber arms automatically transfer the panels to the read station. The specimen number and panel type are interpreted by video image processing. This activates the appropriate incubation cycle and reagent addition for each panel. After appropriate incubation, panels are transferred to the reagent-dispensing station for addition of reagents; after further appropriate incubation, they are returned to the reader for a final examination. Currently, up to nine reagents can be dispensed. Each microtube is examined by a blackand-white video image processor through one to four colored filters selected by the computer, depending on which reaction is being analyzed. The video imaging camera isolates an area of interest for each microtube and uses 200 to 300 picture elements, or pixels, to view this area. For example, fermentation reactions are read at the middle or bottom of the microtube. The density of each pixel perceived by the camera is a specific voltage that is represented digitally for computer processing. These specific results are converted into plus or minus reactions, and the computer generates a seven-digit profile number. This profile number, or "biotype," identifies the most probable organisms of each biotype. The panels are then transferred to the disposal station, where they are discarded into a waste bag by miniature forklifts.
Panels incubated off-line are placed in a tray and read on the UniScept AutoReader or the ALADIN. For the Uni Scept AutoReader, a photometer examines each microwell at multiple positions and wavelengths. A photodiode detects the transmitted light, and the resulting voltage is converted to an optical density value, which is equated to a predetermined positive or negative reaction. The resulting biochemical profile is compared with the data base for identification.
Shulman et al. (105) reported on the ability of the ALA-DIN to read UniScept 20E panels. A total of 300 isolates (144 E. coli, 45 Proteus/Providencia spp., 27 KiebsiellalEnterobacter spp., 18 Serratia spp., 12 Pseudomonas spp., and 54 other organisms) were tested. On a test-for-test basis, the ALADIN and visual readings of 300 organisms showed a 99.0% level of correlation. These differences in readings did not affect the final identification of any of the tested organisms. The reference system to establish the true identity of the organisms and the percentage of organisms correctly identified was not mentioned.
Navarro et al. (86) reported on the ALADIN for its ability to read AN-Ident panels. A total of 125 anaerobes (48 Clostridium spp., 37 Bacteroides spp., 15 Fusobacterium spp., 9Actinomyces spp., 5 Propionibacterium spp., and 11 other organisms) were tested. With respect to visual readings of the 125 organisms, the ALADIN showed a 96.1% level of correlation on a test-for-test basis. The abstract did not mention whether these differences in readings affected VOL. 5, 1992 on October 27, 2017 by guest http://cmr.asm.org/ Downloaded from the final identification of any of the tested organisms by the ALADIN. Also, the reference system to establish the true identity of the organisms and the percentage of organisms correctly identified were not mentioned.
The only extensive report on the ALADIN identification system was a collaborative study at three medical centers (28) (28) and O'Hara et al. (90) indirectly suggest that the ALADIN and UniScept system AutoReader, respectively, will reliably identify isolates with either the UniScept 20E or the ANIdent. However, studies to prove the accuracy of identification of the UniScept 20E, UniScept 20GP, and AN-Ident when tested on these systems have not been reported.
BIOLOG
The Biolog system (Biolog, Inc., Hayward, Calif.) was introduced in 1989 for identification of aerobic gram-negative bacteria (enteric bacilli, nonfermenters, and fastidious species) by determination of carbon source utilization profiles. Recently, Biolog has added the capability to identify a broad range (cocci, bacilli, and spore-forming bacilli) of aerobic gram-positive bacteria. The Biolog GN MicroPlate (for identification of gram-negative bacteria) and the Biolog GP MicroPlate (for identification of gram-positive bacteria) are 96-well dehydrated panels containing tetrazolium violet, a buffered nutrient medium, and a different carbon source for each well except the control, which does not contain a carbon source. The microwells are rehydrated with a cell suspension and read at either 4 h or overnight (16 to 24 h) for the ability of the bacteria to utilize the carbon source. Tetrazolium violet is a redox dye used to detect electrons donated by NADH to the electron transport system. Reduced tetrazolium violet is a purple formazan. When a carbon source is not used, the microwell remains colorless, as does the control well. The resulting pattern of purple wells yields a "metabolic fingerprint" of the bacterium tested (15, 16 The latter software version allows data to be printed and saved in computer files, which can be utilized by userprovided software routines. Alternatively, the data can be filed in a "user data base" in which the reaction patterns are permanently saved. An unknown biochemical profile can be compared with the Biolog GN or Biolog GP data base, the user data base, or a combination of the two. Other features of the software include on-line information about any species in the library, cluster analysis programs in the form of dendrograms and two-dimensional and three-dimensional plots to demonstrate the relatedness of strains or species, and the separation of the GN data base into clinical and environmental versions.
The inoculum for gram-negative organisms is prepared from TSA or TSA-blood agar medium. The inoculum for gram-positive clinical and food isolates, with few exceptions, must be grown on Biolog Universal Growth Medium with 5% sheep's blood (Biolog, Inc.). Environmental isolates typically do not require the addition of blood. Generally, bacteria are grown for 4 to 18 h. A swab is gently rolled over the colonies to prevent carryover of nutrients from the agar medium into the saline (0.85%) suspension of bacteria. The colorimeter or spectrophotometer (optical density at 590 nm of 0) is blanked with a tube containing uninoculated saline. The bacterial suspension is adjusted to within a low-standard-to-high-standard range. The inoculum should be used within 10 min. (80, 81) . Because of the large number of fatty acids found in the cell wall and cell membranes of bacteria and because the composition of cellular fatty acids is a very stable genetic trait that is highly conserved within a taxonomic group, fatty acid composition can be successfully used for identification of bacteria. The MIDI Microbial Identification System (MIS; Microbial ID Inc., Newark, Del.) is a fully automated, computerized, high-resolution gas chromatography system that can analyze more than 300 fatty acid methyl esters ranging in length from 9 to 20 carbons. The MIS computer then searches data bases of known compositions to automatically identify yeasts, anaerobic bacteria, and aerobic bacteria, including mycobacteria. Welch (123) has recently reviewed the applications of cellular fatty acid analysis in clinical microbiology and has described the fatty acid profiles found in various microorganisms.
The MIS data base includes information for identification of 15 genera and 65 species or subspecies of the family Enterobacteriaceae; 45 Pseudomonas species, subspecies, or biovars; 18 Staphylococcus species or subspecies; 19 Bacillus species; and 53 additional genera of aerobic bacteria containing 197 species, subspecies, or biovars. In addition, the MIS data base includes information for identification of 32 species, subgroups, or complexes of mycobacteria; 31 genera of anaerobes containing 254 species, types, or groups; and 23 genera of yeasts including 195 species or subspecies. Periodically, an expanded and updated data base is provided at no cost to users of the system.
The MIS is composed of a gas chromatograph (model 5890A; Hewlett-Packard Co., Avondale, Pa.) equipped with a fused-silica capillary column (25 m The calibration standard used with the MIS is a mixture of straight-chain saturated fatty acids from 9 to 20 carbons in length and five hydroxyl acids. With the calibration mixture, the retention time of the various peaks can be converted to equivalent chain length data for fatty acid identification. The equivalent-chain-length value for each unknown compound is compared with the external standard for peak naming.
Changes in sample injection volume and variables such as carrier gas flow rates and column and detector temperatures will affect the sample retention time. Therefore, the calibration mixture is analyzed after each 10 sample analyses to correct for any possible drift of retention time.
The Library Generation Software allows the user to generate data bases. Extensive evaluations of the MIS for the accurate identification of common and uncommon clinical isolates (aerobes, mycobacteria, yeasts, and anaerobes) and for isolates which are misidentified, unidentified, or identified with a low likelihood by commonly used commercial systems will be required to determine the utility of the MIS in the routine clinical setting. (21) . The authors evaluated the accuracy of the autoSceptor with 570 gram-negative bacilli. Panels read on the autoSceptor were also examined visually, and the biochemical test results were compared. There was more than 97% agreement for biochemical tests, and identification to species on the autoSceptor was 95%. The reference system used to establish the true identity of the isolates was not mentioned.
The disadvantages for the autoSceptor are off-line incubation of panels, manual addition of reagents, and identification of only gram-negative bacilli. The initial report on the autoSceptor is favorable, but this system must be further evaluated to determine its utility in the clinical laboratory.
STUDIES COMPARING AUTOMATED IDENTIFICATION SYSTEMS
Five studies have compared the identification accuracy of either two or three different automated identification systems. Table 5 shows the identification accuracy for each of the automated systems, the percentile (P value) of the chi-square distribution as determined by the chi-square test for each study, and the cited references. The details of how each automated system performed versus the reference system are found earlier in this paper where that particular automated system is reviewed. Table 6 compares various features of the automated identification systems reviewed in this paper.
DISCUSSION
The systems reviewed here vary considerably in their approach to the identification of microorganisms. The MIS, for example, analyzes cellular material, whereas others use more conventional end points such as increase in cell density or color changes due to shifts in pH. There is also some variability in the degree of automation, spectrum of organisms identified, and turnaround time. The constant is that most of these instruments have proven their applicability in clinical microbiology laboratories throughout the country. Specific capabilities, as well as a review of their operation and the details regarding accuracy of identification, are described in the individual sections of this review and will not be summarized in the discussion. Although the systems available today have proven capabilities, there is ample room for improvement and we can expect an expanded range of identification capabilities, shorter turnaround time, and greater automation, particularly in the area of data management, to be available in the future. The devices described here are, with the exception of the Vitek urine card, based on pure culture techniques. In other words, the organism must be isolated before the identification process is performed. There are, however, procedures, both manual and automated, that can identify organisms directly in specimens by using antibodies or nucleic acid probes. We believe that these direct approaches have a very definite but limited utility in the immediate future. For conditions such as meningitis, the consequences of the infection and the expected range of pathogens are limited enough to make such an approach desirable and feasible, but in other situations, such as diarrhea, it would not be economically or often medically justified. A variety of other approaches for identification of microorganisms have been described, such as flow cytometry, image analysis, and mass spectrometry (13, 20, 69) . These all have the potential to provide rapid identification of microorganisms but at present are beyond the scope of the routine clinical microbiology laboratory.
As discussed by Miller (78) tion for what constitutes an accurate or inaccurate test result for automated identification systems and under what circumstances they should be tested, the overall accuracy of the systems is difficult to determine. Miller (78) presents a very good description of steps which could lead to a consensus approach to resolve many of the issues that have plagued us during our review of the literature on automated identification systems. We are unable to objectively answer the question of which instrument is best for which application. Among the many reasons is that the accuracy of a system is highly dependent on the organisms tested and that these populations are never the same in the various studies. Also, by the time a study is reported, the manufacturer has often changed the data base, altered thresholds on the reader, or modified, added, or replaced some of the substrates. In addition, some studies have used photometrically standardized inocula, whereas others have used generally less reliable visually prepared inocula. Also, the reference system in some studies may not always yield the correct identification, and hence the system under study can be unfairly penalized.
In a recent reevaluation of the API 20E, O'Hara et al'. (89) showed that a system did not even necessarily provide the same level of accuracy over time. They were not able to explain why this was so, but an obvious difference was an expanded data base. The list of variables goes on! However, it is obvious from the literature that automated systems accurately identify common clinical isolates. Rare biotypes of common organisms and unusual organisms are often misidentified, identified at low likelihood, or not identified. How effective are automated identification systems in determining the relatedness of isolates for epidemiologic purposes? The Biolog system and the MIS have cluster analysis programs in the form of dendrograms and twodimensional or three-dimensional plots to demonstrate the relatedness of strains or species. There are, however, only limited reports on the effectiveness of these systems for epidemiologic purposes. Wong (124) used the Biolog system to test Brucella strains which were isolated from commonsource infections or laboratory accidents and found that strains that were epidemiologically related did have similar metabolic profiles. However, it was not indicated whether cluster analysis or dendrograms were used in that study. The study suggested that the Biolog system should prove useful in epidemiologic studies. Mukwaya and Welch (84) used the MIS to determine the cellular fatty acid profiles for 42 strains of P. cepacia isolated from patients at five cystic fibrosis centers and found, through numerical analysis of the data, that a different subgroup was present at each of the centers. Clarridge and Harrison (23) evaluated the MIS for strain differentiation of X. maltophilia from the surgical intensive care unit (7 strains) and medical intensive care unit (9 strains) in a hospital. When Although it is difficult to imagine a more exciting and stimulating period for clinical microbiologists than the recent past, the immediate future appears to be at least as stimulating.
